GlassScriptPhysician profile
Susan Danziger
NPI 1376545715
$1,356.25
in general payments reported to CMS, 2019-2025
18 companies · $412 in 2025
The $412 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2021: $13.62 · 2022: $185 · 2023: $202 · 2024: $241 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $854.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $376.63 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $164.97 | 2019-2022 | |
| Ars Pharmaceuticals Operations, INC. | $161.13 | 2025 | Neffy |
| Pfizer INC. | $119.53 | 2019-2023 | |
| Kaleo, INC. | $111.57 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $72.47 | 2022-2025 | Vpriv, Elaprase |
| Merck Sharp & Dohme LLC | $58.83 | 2019-2022 | |
| Ultragenyx Pharmaceutical INC. | $45.65 | 2023-2024 | Crysvita, Crysvita |
| Cranial Technologies, INC | $43.69 | 2022-2024 | Doc Band |
| Vertical Pharmaceuticals, LLC | $40.30 | 2025 | Relexxii |
| Sanofi Pasteur INC. | $39.53 | 2023 | |
| Acadia Pharmaceuticals INC | $29.75 | 2024 | Daybue |
| Supernus Pharmaceuticals, INC. | $21.76 | 2024 | Qelbree |
| Mission Pharmacal Company | $15.17 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $15.00 | 2023 | Kristalose |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $13.81 | 2024 | Karbinal |
| Phadia US INC. | $13.69 | 2023 | Immunocap |
| Sobi, INC | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Danziger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.